Do we mix Adrenaline (Epinephrine) with Normal Saline for Anaphylaxis treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Administration in Anaphylaxis

For anaphylaxis treatment, you should NOT mix 0.5ml of 1mg/ml adrenaline (1:1000) with 10ml normal saline for routine administration. Epinephrine should be administered intramuscularly as the first-line treatment, without dilution.

First-Line Treatment: Intramuscular Epinephrine

  • Dose and Route: Administer epinephrine 0.01 mg/kg (maximum 0.5 mg in adults, 0.3 mg in children) intramuscularly into the anterolateral thigh 1
  • Concentration: Use 1:1000 (1 mg/mL) solution for IM injection 1
  • Timing: Repeat every 5-15 minutes if symptoms persist 1

When to Consider IV Epinephrine

Intravenous epinephrine (including diluted preparations) should ONLY be used in specific circumstances:

  1. For patients with cardiac arrest due to anaphylaxis 2
  2. For profoundly hypotensive patients who have failed to respond to:
    • Intravenous volume replacement AND
    • Several injected doses of epinephrine 2

IV Epinephrine Administration (Only if Indicated)

If IV epinephrine is deemed essential after failure of IM injections in a profoundly hypotensive patient:

  • Option 1: Aqueous epinephrine 1:1000,0.1 to 0.3 mL in 10 mL of normal saline, administered intravenously over several minutes 2
  • Option 2: Epinephrine infusion prepared by adding 1 mg (1 mL) of 1:1000 dilution to 250 mL of D5W (concentration 4.0 μg/mL), infused at 1-4 μg/min 2
  • Option 3: Alternative 1:100,000 solution (1 mg in 100 mL saline) administered at 30-100 mL/h (5-15 μg/min) 2

Critical Safety Considerations

  • WARNING: IV epinephrine carries risk of potentially lethal arrhythmias 2
  • Monitoring: Continuous hemodynamic monitoring is essential when administering IV epinephrine 2
  • Setting: IV epinephrine is best administered in settings with appropriate monitoring (emergency department or intensive care) 2

Additional Management Steps

  1. Position: Place patient in recumbent position with elevated lower extremities 2
  2. Airway: Establish and maintain airway; consider endotracheal intubation if necessary 2
  3. Oxygen: Administer oxygen to patients with prolonged reactions, pre-existing hypoxemia, or requiring multiple epinephrine doses 2
  4. Fluids: Establish IV access with normal saline; administer 1-2 L to adults at 5-10 mL/kg in first 5 minutes 2
  5. Adjunctive medications: Consider diphenhydramine (25-50 mg) and ranitidine (50 mg in adults) as second-line therapy 2

Common Pitfalls to Avoid

  • Delay in epinephrine administration: Failure to inject epinephrine promptly contributes to anaphylaxis fatalities 3
  • Inappropriate route: Subcutaneous injection delays onset of action; IV injection increases risk of adverse effects 3
  • Reliance on antihistamines alone: Antihistamines should never be administered alone in anaphylaxis treatment 2
  • Inadequate monitoring: Patients require close monitoring due to potential for rapid changes in cardiovascular and respiratory status 2

Remember that epinephrine is the cornerstone of anaphylaxis management, and its administration should be immediate upon recognition of anaphylactic symptoms 4. No other medication has similar life-saving effects in multiple organ systems 3.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Research

The role of epinephrine in the treatment of anaphylaxis.

Current allergy and asthma reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.